Paul Tudor Jones II acquired 4.6 Thousand Dexcom shares worth $389 Thousand. That's 0.00% of their equity portfolio (1189th largest holding). The first Dexcom trade was made in Q4 2013. Since then Paul Tudor Jones II bought shares 22 more times and sold shares on 27 occasions. The stake costed the investor $342 Thousand, netting the investor a gain of 14% so far.